SUMO1/UBC9‑decreased Nox1 activity inhibits reactive oxygen species generation and apoptosis in diabetic retinopathy

Hu,Jiaoli; Xue,Pengcheng; Mao,Xinbang; Xie,Lin; Li,Guodong; You,Zhipeng

doi:10.3892/mmr.2017.8037

SUMO1/UBC9‑decreased Nox1 activity inhibits reactive oxygen species generation and apoptosis in diabetic retinopathy

Authors:
- Jiaoli Hu
- Pengcheng Xue
- Xinbang Mao
- Lin Xie
- Guodong Li
- Zhipeng You
View Affiliations

Affiliations: Department of Ophthalmology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: November 13, 2017 https://doi.org/10.3892/mmr.2017.8037
Pages: 1690-1698
Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Diabetic retinopathy (DR) is an increasing global health concern that causes vision loss and blindness. Reactive oxygen species (ROS) are considered to be a principal cause of DR. An important source of ROS is the oxidization of NADPH. In the present study, NADPH oxidase 1 (Nox1)‑expressing human retinal epithelial cell (HREC) lines were generated and infected with small ubiquitin‑like modifier 1 (SUMO1) and/or ubiquitin conjugating enzyme E2 I (UBC9) lentiviral pGMLV constructs. The viabilities, apoptotic capacities and ROS production levels of the HREC lines were quantified using Hoechst 33258, annexin V/propidium iodide and dichlorodihydrofluorescein diacetate assays, respectively. Additionally, rat DR models were established. From these models, the apoptotic capacities of retinal tissues were visualized using terminal deoxynucleotidyl transferase dUTP nick end labeling assays, and the pathologies were evaluated. The mRNA and protein expression levels of SUMO1, UBC9 and Nox1 were analyzed using reverse transcription‑quantitative polymerase chain reaction and western blot analyses, respectively. Compared with controls, the relative mRNA levels of SUMO1 and UBC9 were significantly upregulated, and the Nox1 levels significantly downregulated, in cells infected with SUMO1 or UBC9 alone or in combination. The ROS production and apoptosis rates of cells and retinal tissues were decreased. In addition, pathological symptoms in DR tissues improved when they were simultaneously transfected with SUMO1 and UBC9 via intraocular injection. In conclusion, the SUMO1/UBC9 axis may regulate Nox1‑mediated DR by inhibiting ROS generation and apoptosis in rat and cellular model systems.

View Figures

View References

1	Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, Gregg EW, Albright AL, Klein BE and Klein R: Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA. 304:649–656. 2010. View Article : Google Scholar :
2	Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL III and Klein R: American DiabetesAssociation: Retinopathy in diabetes. Diabetes Care. 27 Suppl 1:S84–S87. 2004. View Article : Google Scholar
3	Klein R, Klein BEK, Moss SE, Davis MD and DeMets DL: The wisconsin epidemiologic study of diabetic retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. JAMA Ophthalmol. 102:520–526. 1984.
4	Behl T, Kaur I and Kotwani A: Implication of oxidative stress in progression of diabetic retinopathy. Surv Ophthalmol. 61:187–196. 2016. View Article : Google Scholar
5	Safi SZ, Qvist R, Kumar S, Batumalaie K and Ismail IS: Molecular mechanisms of diabetic retinopathy, general preventive strategies, and novel therapeutic targets. Biomed Res Int. 2014:8012692014. View Article : Google Scholar :
6	Schippers JH, Nguyen HM, Lu D, Schmidt R and Mueller-Roeber B: ROS homeostasis during development: An evolutionary conserved strategy. Cell Mol Life Sci. 69:3245–3257. 2012. View Article : Google Scholar
7	Wilkinson-Berka JL, Rana I, Armani R and Agrotis A: Reactive oxygen species, Nox and angiotensin II in angiogenesis: Implications for retinopathy. Clin Sci. (Lond.). 124:597–615. 2013.
8	Bondeva T and Wolf G: Reactive oxygen species in diabetic nephropathy: Friend or foe? Nephrol Dial Transplant. 29:1998–2003. 2014. View Article : Google Scholar
9	Brandes RP, Weissmann N and Schröder K: Nox family NADPH oxidases: Molecular mechanisms of activation. Free Radic Biol Med. 76:208–226. 2014. View Article : Google Scholar
10	Dvoriantchikova G, Grant J, Santos AR, Hernandez E and Ivanov D: Neuronal NAD(P)H oxidases contribute to ROS production and mediate RGC death after ischemia. Invest Ophthalmol Vis Sci. 53:2823–2830. 2012. View Article : Google Scholar :
11	Gill G: SUMO and ubiquitin in the nucleus: Different functions, similar mechanisms? Genes Dev. 18:2046–2059. 2004. View Article : Google Scholar
12	Johnson ES: Protein modification by SUMO. Annu Rev Biochem. 73:355–382. 2004. View Article : Google Scholar
13	Hwang KW, Won TJ, Kim H, Chun HJ, Chun T and Park Y: Characterization of the regulatory roles of the SUMO. Diabetes Metab Res Rev. 27:854–861. 2011. View Article : Google Scholar
14	Pandey D, Chen F, Patel A, Wang CY, Dimitropoulou C, Patel VS, Rudic RD, Stepp DW and Fulton DJ: SUMO1 negatively regulates reactive oxygen species production from NADPH oxidases. Arterioscler Thromb Vasc Biol. 31:1634–1642. 2011. View Article : Google Scholar :
15	Kim HJ, Yun J, Lee J, Hong H, Jeong J, Kim E, Bae YS and Lee KJ: SUMO1 attenuates stress-induced ROS generation by inhibiting NADPH oxidase 2. Biochem Biophys Res Commun. 410:555–562. 2011. View Article : Google Scholar
16	Gimenez M, Schickling BM, Lopes LR and Miller FJ Jr: Nox1 in cardiovascular diseases: Regulation and pathophysiology. Clin Sci (Lond). 130:151–165. 2016. View Article : Google Scholar
17	Chhunchha B, Fatma N, Kubo E and Singh DP: Aberrant sumoylation signaling evoked by reactive oxygen species impairs protective function of Prdx6 by destabilization and repression of its transcription. FEBS J. 281:3357–3381. 2014. View Article : Google Scholar :
18	Li M, Guo D, Isales CM, Eizirik DL, Atkinson M, She JX and Wang CY: SUMO wrestling with type 1 diabetes. J Mol Med (Berl). 83:504–513. 2005. View Article : Google Scholar
19	Arden GB and Sivaprasad S: Hypoxia and oxidative stress in the causation of diabetic retinopathy. Current Diabetes Rev. 7:291–304. 2011. View Article : Google Scholar
20	Liu GD, Xu C, Feng L and Wang F: The augmentation of O-GlcNAcylation reduces glyoxal-induced cell injury by attenuating oxidative stress in human retinal microvascular endothelial cells. Int J Mol Med. 36:1019–1027. 2015. View Article : Google Scholar :
21	Banskota S, Regmi SC and Kim JA: NOX1 to NOX2 switch deactivates AMPK and induces invasive phenotype in colon cancer cells through overexpression of MMP-7. Mol Cancer. 14:1232015. View Article : Google Scholar :
22	Valente AJ, El Jamali A, Epperson TK, Gamez MJ, Pearson DW and Clark RA: NOX1 NADPH oxidase regulation by the NOXA1 SH3 domain. Free Radic Biol Med. 43:384–396. 2007. View Article : Google Scholar
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
24	Li Z, Ma L, Chen X, Li Y, Li S, Zhang J and Lu L: Glycogen synthase kinase-3: A key kinase in retinal neuron apoptosis in early diabetic retinopathy. Chin Med J (Engl.). 127:3464–3470. 2014.
25	Jia J, Zhang X, Hu YS, Wu Y, Wang QZ, Li NN, Guo QC and Dong XC: Evaluation of in vivo antioxidant activities of Ganoderma lucidum, polysaccharides in STZ-diabetic rats. Food Chem. 115:32–36. 2009. View Article : Google Scholar
26	Gong CY, Lu B, Hu QW and Ji LL: Streptozotocin induced diabetic retinopathy in rat and the expression of vascular endothelial growth factor and its receptor. Int J Ophthalmol. 6:573–577. 2013.
27	Xiao X, Cai J, Xu J, Wang R, Cai J, Liu Y, Xu W, Sun X and Li R: Protective effects of hydrogen saline on diabetic retinopathy in a streptozotocin-induced diabetic rat model. J Ocul Pharmacol Ther. 28:76–82. 2012. View Article : Google Scholar
28	Hong Y, Rogers R, Matunis MJ, Mayhew CN, Goodson ML, Park-Sarge OK and Sarge KD: Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J Biol Chem. 276:40263–40267. 2001. View Article : Google Scholar
29	Shishido T, Woo CH, Ding B, McClain C, Molina CA, Yan C, Yang J and Abe J: Effects of MEK5/ERK5 association on small ubiquitin-related modification of ERK5: Implications for diabetic ventricular dysfunction after myocardial infarction. Circ Res. 102:1416–1425. 2008. View Article : Google Scholar :
30	Luciani A, Villella VR, Vasaturo A, Giardino I, Raia V, Pettoello-Mantovani M, D'Apolito M, Guido S, Leal T, Quaratino S and Maiuri L: SUMOylation of tissue transglutaminase as link between oxidative stress and inflammation. J Immunol. 183:2775–2784. 2009. View Article : Google Scholar
31	Kurtzman AL and Schechter N: Ubc9 interacts with a nuclear localization signal and mediates nuclear localization of the paired-like homeobox protein Vsx-1 independent of SUMO-1 modification. Proc Natl Acad Sci USA. 98:5602–5607. 2001. View Article : Google Scholar :